SRDX News and Press, Surmodics Inc. From 02/03/22

Surmodics, Inc. (SRDX) Q1 2022 Earnings Conference Call February 03, 2022 8:30 AM ET Company Participants Tim Arens - SVP, Finance & CFO Gary Maharaj - President & CEO Conference Call Participants Brooks O’Neil - Lake Street Capital Markets David Saxon - Needham and Company Mik...

Surmodics (SRDX -10.8%) shares crashed to a 52-week low after the medical device maker reported worse than expected revenue for Q1 fiscal 2022, and its guidance missed forecasts. The revenue for the quarter rose ~3% YoY to reach $23.0M falling short of $23.7M in the consensus, while non-GAAP ...

The following slide deck was published by Surmodics, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Surmodics, Inc. 2022 Q1 - Results - Earnings Call Presentation

Surmodics press release (NASDAQ:SRDX): FQ1 Non-GAAP EPS of -$0.13. Revenue of $23M (+3.1% Y/Y). Surmodics expects fiscal year 2022 revenue to range from $97 million to $101 million vs. consensus of $105.00M. The Company expects fiscal 2022 diluted GAAP EPS to range from a loss per share of $(...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2022 first quarter ended December 31, 2021. Summary of First Quarter and Recent Highlights Revenue o...

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its first quarter fiscal 2022 conference call on Th...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appoin...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...